Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 21 Dec 2012  |  North America

    2013 Projected Global Laboratory Products Budgets

    Brands Named, Purchasing Trends Identified

    This survey of 170 laboratory managers and researchers investigates budgets for these product categories: instruments, equipment, chemicals, life science reagents and kits, glassware, plasticware, and general laboratory supplies over the 2011-2013 period. Budgets for service and repair of instruments and equipment also are presented. Additionally,...

    $10,000.00
  2. 26 Nov 2012  |  North America

    Global Quantitative and dPCR Instrumentation and Consumables Purchasing Trends

    Opportunities Within Organizations

    The primary objective of this research is to identify trends for quantitative polymerase chain reaction (PCR) techniques, specifically the use of nascent digital PCR (dPCR) technology in comparison with the mature real-time quantitative PCR (qPCR) technology. The research strives to compare differences of current and future use between qPCR and dPC...

    $10,000.00
  3. 27 Sep 2012  |  North America

    2009 United States Oncology Drug Delivery Patterns, Preferences, and Opportunities

    Volume 1: Oncologist and Infusion Nurse Perspectives

    Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients; identify physicians prescribing trends relative to delivery considerations; understand the role of reimburs...

    $10,000.00
  4. 31 Jul 2012  |  North America

    Understanding the Peripheral Intervention Toolkit

    An Analysis of Trends, Strategies, and Opportunities in the U.S. Peripheral Intervention Market

    In February 2010, Frost & Sullivan surveyed 157 vascular surgeons, interventional cardiologists, and interventional radiologists on a broad range of issues relating to peripheral intervention procedures. This study is based on their responses to an extensive online questionnaire. The study addresses balloons and stents, atherectomy devices, thrombe...

    $10,000.00
  5. 24 May 2012  |  North America

    Purchasing Trends in the Research Antibodies Market

    Evaluating Budgets, Suppliers, and Unmet Needs

    This study is based on input from 1,155 laboratory personnel who either participate in their laboratory's purchase of antibodies or are users of antibodies. Most survey participants are located in the United States, although participation was open to researchers globally. The objectives of this research are to identify points such as: types of rese...

    $10,000.00
  6. 08 May 2012  |  North America

    Global Laboratory Product Purchasing Trends

    A Survey of Laboratory Managers, Directors, Technicians, and Scientists

    This study is based on a survey of 151 laboratory professionals working in a variety of laboratory types. They reveal their laboratories' current (2011) budgets and anticipated budget trends (for 2012) in seven product categories, and the top brands in each of these categories. The product categories and the brand with the highest unaided brand rec...

    $10,000.00
  7. 26 Mar 2012  |  North America

    Investment Confidence Among Laboratory Decision Makers

    In What Laboratory Products do Decision Makers Expect to Invest?

    The study investigates investment decisions of healthcare-related laboratory decision makers. It shows that 2011 was tumultuous for the laboratory industry. In comparison, the outlook for 2012 looks only slightly positive. In particular, laboratory decision makers generally expect their funding conditions to either remain the same or minimally impr...

    $10,000.00
  8. 20 Dec 2011  |  North America

    Frost & Sullivan 2011 Survey of Sequencing Technologies: Instrument Adoption on the Rise as Affordable Systems Enter the Market

    Frost & Sullivan 2011 Survey of Sequencing Technologies

    The editors of Lab Manager Magazine and Frost & Sullivan recently conducted a survey to better understand the sequencing end-user base. A total of 79 Lab Manager Magazine readers qualified for the survey as current or future users of sequencing technology, representing research and clinical laboratories, core facilities, sequencing services provide...

    $10,000.00
  9. 12 Dec 2011  |  North America

    Social Media Use Among the U.S. Healthcare Provider Institutions

    Opportunities and Concerns for Social Media in Healthcare

    Professional usage of social media (both individual and within institutional frames) is high within healthcare providers institutions. However, only a minority of provider institutions have a dedicated budget for social media. The majority of employees have access to social media in their workplace, but the majority of provider institutions using s...

    $4,950.00
  10. 08 Dec 2011  |  North America

    Specialty Physicians Discuss their Opinions of the United States Biosimilars Market

    Insights into the Potential Reactions of Key Customers and Influence on Market Uptake

    The U.S. biosimilars market is a fast approaching reality. However, much uncertainty lies ahead, including the market potential as a function of physician adoption of biosimilars. This panel discussion was conducted to preview the thoughts and expectations of specialty physicians who would be expected to be among the first customers of biosimilar...

    $10,000.00